Doyle Mittie
CIK: 0001918845
Director
Primary company: Avalo Therapeutics, Inc. (AVTX)
Doyle Mittie is a corporate insider at Avalo Therapeutics, Inc. (AVTX) filing SEC Form 4 transactions. 20 transactions across 3 companies. Source: SEC EDGAR.
Companies
Transaction History
Source: SEC EDGAR Form 4 insider transaction filings.
Company | Type | Shares | Price | Value | Shares After | Date | SEC |
|---|---|---|---|---|---|---|---|
| Exercise | 1,450 | $8.04 | $12K | 116,871 | 6/23/2026 Filed: 6/23/2026 | Filing → | |
| Sale | 1,450 | $18.00 | $26K | 51,776 | 6/23/2026 Filed: 6/23/2026 | Filing → | |
| Exercise | 1,450 | $8.04 | $12K | 53,226 | 6/23/2026 Filed: 6/23/2026 | Filing → | |
| Exercise | 3,970 | $12.65 | $50K | 210,530 | 4/6/2026 Filed: 4/8/2026 | Filing → | |
| Sale | 3,970 | $18.01 | $72K | 3,622 | 4/6/2026 Filed: 4/8/2026 | Filing → | |
| Exercise | 3,970 | $12.65 | $50K | 7,592 | 4/6/2026 Filed: 4/8/2026 | Filing → | |
| Exercise | 679 | $8.04 | $5K | 148,329 | 4/1/2026 Filed: 4/1/2026 | Filing → | |
| Sale | 679 | $16.00 | $11K | 3,622 | 4/1/2026 Filed: 4/1/2026 | Filing → | |
| Exercise | 679 | $8.04 | $5K | 4,301 | 4/1/2026 Filed: 4/1/2026 | Filing → | |
| Exercise | 5,992 | $8.04 | $48K | 149,008 | 3/16/2026 Filed: 3/16/2026 | Filing → | |
| Exercise | 19,500 | $12.65 | $247K | 214,500 | 3/16/2026 Filed: 3/16/2026 | Filing → | |
| Sale | 25,492 | $16.15 | $412K | 3,622 | 3/16/2026 Filed: 3/16/2026 | Filing → | |
| Exercise | 5,992 | $8.04 | $48K | 29,114 | 3/16/2026 Filed: 3/16/2026 | Filing → | |
| Exercise | 19,500 | $12.65 | $247K | 23,122 | 3/16/2026 Filed: 3/16/2026 | Filing → | |
| Tax Payment | 1,013 | $4.10 | $4K | 3,622 | 12/10/2025 Filed: 12/12/2025 | Filing → | |
| Award | 79,456 | - | - | 79,456 | 8/7/2025 Filed: 8/8/2025 | Filing → | |
| Award | 155,000 | $8.04 | $1.25M | 155,000 | 1/28/2025 Filed: 1/30/2025 | Filing → | |
| Award | 234,000 | - | - | 234,000 | 7/15/2024 Filed: 7/16/2024 | Filing → | |
DICE Therapeutics, Inc. DICE | Disposition | 42,500 | - | - | 0 | 8/9/2023 Filed: 8/9/2023 | Filing → |
DICE Therapeutics, Inc. DICE | Award | 42,500 | $0.00 | $0 | 42,500 | 3/31/2022 Filed: 4/1/2022 | Filing → |
Type
Exercise
Shares
1,450
Price
$8.04
Value
$12K
Type
Sale
Shares
1,450
Price
$18.00
Value
$26K
Type
Exercise
Shares
1,450
Price
$8.04
Value
$12K
Type
Exercise
Shares
3,970
Price
$12.65
Value
$50K
Type
Sale
Shares
3,970
Price
$18.01
Value
$72K
Type
Exercise
Shares
3,970
Price
$12.65
Value
$50K
Type
Exercise
Shares
679
Price
$8.04
Value
$5K
Type
Sale
Shares
679
Price
$16.00
Value
$11K
Type
Exercise
Shares
679
Price
$8.04
Value
$5K
Type
Exercise
Shares
5,992
Price
$8.04
Value
$48K
Type
Exercise
Shares
19,500
Price
$12.65
Value
$247K
Type
Sale
Shares
25,492
Price
$16.15
Value
$412K
Type
Exercise
Shares
5,992
Price
$8.04
Value
$48K
Type
Exercise
Shares
19,500
Price
$12.65
Value
$247K
Type
Tax Payment
Shares
1,013
Price
$4.10
Value
$4K
Type
Award
Shares
79,456
Price
-
Value
-
Type
Award
Shares
155,000
Price
$8.04
Value
$1.25M
Type
Award
Shares
234,000
Price
-
Value
-
DICE Therapeutics, Inc.
DICE
Type
Disposition
Shares
42,500
Price
-
Value
-
DICE Therapeutics, Inc.
DICE
Type
Award
Shares
42,500
Price
$0.00
Value
$0
AI Agent
Try asking...